Parkinsons disease and its chemotherapy

作者: Oleh Hornykiewicz

DOI: 10.1016/0006-2952(75)90190-2

关键词: OncologyInternal medicineDiseaseChemotherapyMedicine

摘要:

参考文章(17)
Kjell Fuxe, Tomas Hökfelt, Urban Ungerstedt, Morphological and Functional Aspects of Central Monoamine Neurons International Review of Neurobiology. ,vol. 13, pp. 93- 126 ,(1970) , 10.1016/S0074-7742(08)60167-1
H. Bernheimer, W. Birkmayer, O. Hornykiewicz, K. Jellinger, F. Seitelberger, Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations Journal of the Neurological Sciences. ,vol. 20, pp. 415- 455 ,(1973) , 10.1016/0022-510X(73)90175-5
L. J. POIRIER, T. L. SOURKES, INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM Brain. ,vol. 88, pp. 181- 192 ,(1965) , 10.1093/BRAIN/88.1.181
R. Ferrini, G. Miragoli, Selective antagonism of dopamine by apomorphine Pharmacological Research Communications. ,vol. 4, pp. 347- 352 ,(1972) , 10.1016/0031-6989(72)90022-7
RICHARD MILLER, ALAN HORN, LESLIE IVERSEN, ROGER PINDER, Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography. Nature. ,vol. 250, pp. 238- 241 ,(1974) , 10.1038/250238A0
Oleh Hornykiewicz, The mechanisms of action of L-dopa in Parkinson's disease. Life Sciences. ,vol. 15, pp. 1249- 1259 ,(1974) , 10.1016/0024-3205(74)90306-3
L. Davidson, K. Lloyd, J. Dankova, O. Hornykiewicz, l-DOPA treatment in Parkinson's disease: Effect on dopamine and related substances in discrete brain regions Cellular and Molecular Life Sciences. ,vol. 27, pp. 1048- 1049 ,(1971) , 10.1007/BF02138873
P.L. McGeer, E.G. McGeer, H.C. Fibiger, V. Wickson, Neostriatal choline acetylase and cholinesterase following selective brain lesions Brain Research. ,vol. 35, pp. 308- 314 ,(1971) , 10.1016/0006-8993(71)90625-1